reported in youarewithinthenorms.com‘
NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC., SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., M.B.A., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, IN THE SPIRIT OF WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
DEA’s ORDER TO SHOW CAUSE AT COST PHARMACY, FT. MEYERS, FL.
This document, analyzed by The Project North Star, is a formal Immediate Suspension of Registration and Order to Show Cause issued by the U.S. Drug Enforcement Administration (DEA) against the pharmacy AARRIC, Inc.
The DEA initiated this action due to the pharmacy’s repeated failure to “adhere to federal and state regulations,” specifically accusing AARRIC of routinely filling prescriptions that exhibited multiple “red flags” of drug abuse and diversion.
Detailed evidence is then presented, focusing on the improper dispensing of highly addictive “cocktail medications”—combinations of “opioids and benzodiazepines”—and serving patients who traveled “long distances” to obtain unusually high quantities of controlled substances.
THE IMMINENT DANGER
BREAKDOWN OF DEA’S ORDER TO SHOW CAUSE: AT COST PHARMACY
The Project North Star Group Deep Dive Analysis, DEA’s manufactured legal basis for Targeting and Immediate Suspension Red Flags: of At Cost Pharmacy, Ft Myers, Florida
Because the continuation of these practices constitutes an “imminent danger” to public health and safety, the order demands the immediate halt of all controlled substance dispensing pending a formal administrative hearing.
https:youarewithinthenorms.com:wp-content:uploads:2020:02:ah_1072020_aarric_dea_dsa-2
LEROY BAYLOR OF HARLEM WIDOM TABLET INTERVIEWS JACK FOLSON, PHARMACIST EXPERT ON DEA TARGETING AND MANIPULATION OF PAIN CARE TREATMENT PROTOCOLS
DEA’S CASE FILE OF OVERREACH TARGETING AND DECEPTION AGAINST AARON HOWARD THE AT-COST PHARMACIST OWNER
The order was issued by the U.S. Department of Justice, Drug Enforcement Administration, against AARRIC, Inc., operating at 16970 San Carlos Boulevard, Suite 110, Fort Myers, Florida 33908. The PowerPoint Presentation exemplifies how the DEA has criminalized routine pharmaceutical dispensing protocols; The Project North Star Group’s studies on DEA incompetence and willful misidentification in targeting Black Owned Pharmacies
• Action: Order to Show Cause and Immediate Suspension of Registration.
• DEA Registration Number: FA2125640.
• Date of Order: January 3, 2020.
• Legal Basis: The action was taken pursuant to the Controlled Substances Act (Title 21, U.S.C. §§ 823 and 824). The DEA determined that AARRIC’s “continued registration constitutes an imminent danger to the public health or safety” and that there is a “substantial likelihood of an immediate threat that death or serious bodily harm, or abuse of a controlled substance will occur” if the pharmacy continues to operate.
Core Allegations: A Pattern of Unresolved Red Flags
The DEA’s investigation, which included a review of prescriptions, patient profiles, and data from Florida’s prescription drug monitoring program (E-FORSCE), concluded that from February 2018 to September 2019, AARRIC engaged in “long-standing and pervasive violations” of federal and state regulations by repeatedly ignoring clear indicators of potential drug abuse and diversion.
1. Dispensing of “Cocktail Medications”
AARRIC repeatedly dispensed “cocktail medications,” which are combinations of controlled substances known to be abused or diverted together to enhance euphoric effects.
The primary combination of concern involves opioids (such as hydromorphone, oxycodone, and morphine) dispensed alongside central nervous system depressants, particularly benzodiazepines (such as alprazolam and temazepam).
The DEA’s expert noted that this practice directly contradicts guidelines from the Centers for Disease Control and Prevention (CDC) that highlight the significant overdose risk posed by combining these drug classes.
DEA DISPLAYED AN EXTREME LACK OF KNOWLEDGE OF PHARMACEUTICAL MEDICAL PRACTICES.
The Form: A Memorandum For Record
Pronto Pharmacy also had a required “Form” (MEMORANDUM FOR RECORD) that every patient with any type of prescription had to fill out. The Form was used along with the National Prescription Drug Monitoring Program to screen for suspicious activity of control medications.
The Form was very successful in detecting fraudulent prescriptions and groups engaged in “pharmacy shopping” for diversion purposes. People who were up to “no good” would turn around and leave when they were made aware of the Memorandum For Record “The Form” and the consequences of not being truthful.
Richard James Alpert was knowledgeable about the Pronto Pharmacy’s purpose. However, Mr. Albert chose not to see “The Form” as a tool for deterring suspicious activity. His disregard for the Pronto Pharmacy “Form” further shows his failure to conduct a thorough investigation and uncover the truth. “Form” and its
As noted from Mr. Albert’s court testimony, he didn’t actually speak with any prescribing physicians or their patients. Richard James Alpert was informed and fully aware that no one who visited Pronto Pharmacy had prescriptions filled without completing the required form. Everyone received a consultation and paid a one-time fee of $25.
The Project North Star Group found the D.E.A. warrant identified items that are evidence of violations of 21 U.S.C. §§ 841(a)(1) (possession with the intent to distribute and distribution of oxycodone and hydromorphone).
The purpose of this law implies that it shall be unlawful for any person knowingly or intentionally to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance; or to create, distribute, or dispense, or possess with intent to distribute or dispense, a counterfeit substance.
The DEA uses the law with the intent to imply licensed Pharmacists and medical professionals as persons who illegally distribute or dispense controlled substances.
The DEA has deliberately reinterpreted the law to support its effort to attack pharmacists. In essence, the DEA willfully and knowingly misled the courts that the petitioner, a licensed pharmacist, violated 21 U.S.C. §§ 841(a)(1) (possession with the intent to distribute and distribution of oxycodone and hydromorphone. The officers should be charged under Giglio. As a licensed pharmacist, the Petitioner carried out his fiduciary responsibility. Aaron Howard was acting in the capacity of a licensed pharmacist.
Whereby a Pharmacist is a person who is professionally qualified to prepare and dispense the medicinal drug.
This definition and is a statute within the Florida Administrative Code & Florida Administrative Register. The officer acted upon an oath to enter the premises to secure evidence of violations of 21 U.S.C. §§ 841(a)(1) (possession with the intent to distribute and distribution of oxycodone and hydromorphone.
In this and other cases, the DEA Diversion Investigator falsely established diversion based solely on the use of Google Maps and performed absolutely no follow-up investigation, as found in Wheatland Pharmacy, 78 FR 69441, 69445 (2013), to establish diversion or evidence that any patients had diverted any prescription medication filled by pharmacists from At Cost Pharmacy.
Similar misconduct by the DEA Diversion Investigation is on the record in investigations of Pronto Pharmacy LLC, Tampa, FL; Lincourt Pharmacy LLC, Clearwater, FL; Superior Pharmacy, Tampa, FL; and Gulf-Med Pharmacy, Cape Coral, FL.
Such acts to search to find without a stated cause for the search are an investigative function that violates the premise of a search warrant and violates the basis of Probable Cause, and elements of Reasonable Suspicion. The search was not specific, and the agents confiscated items not covered by the warrant.
The removal of such documents and items serves no purpose other than to develop a case beyond the scope and statutes of the search. The intent is that a person, not a sold medication, be criminalized, and that the job of a licensed Pharmacist be criminalized.
The Fourth Amendment was intended to create a constitutional buffer between U.S. citizens and the intimidating power of law enforcement. The officers failed to specify in their search warrant the components to be seized. The officers exercised undue discretion when they chose to search and seize.
Therefore, the defendant’s interest was violated when the search and seizures became “unreasonable” and were not authorized by a warrant based on probable cause to remove personal artifacts, such as academic research documents.
ALL WATCHED OVER BY MACHINES OF LOVING GRACE
DONATE THIS HOLY DAY SEASON TO MAINTAINING THIS BLOG. YOU ARE WITHIN THE NORMS FIGHT FOR PAIN CARE JUSTICE TO ZELLE 3135103378
OR TO CASH APP:$docnorm
BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!
“..one day you will make a difference..”
FOR NOW, YOU ARE WITHIN
THE NORMS
REFERENCES:
